Antares Pharma, Inc. Announces Pricing of Public Offering of Common Stock
Published: Oct 03, 2012
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that it has priced a firm commitment underwritten public offering of 12,500,000 shares of the Company’s common stock at a purchase price to the public of $4.00 per share, resulting in net proceeds to the Company of $47 million (before estimated offering expenses payable by us). Jefferies & Company, Inc. and Oppenheimer and Co. Inc. are acting as joint book-running managers for the offering. Cowen and Company, LLC and Ladenburg Thalmann & Co. Inc. are acting as the co-managers of the offering. The offering is expected to close on or about October 8, 2012, subject to customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to 1,875,000 additional shares of common stock.